1. Effect of a thiohydantoin salt derived from l-Arginine on Leishmania amazonensis and infected cells: Insights from biological effects to molecular docking interactions.
- Author
-
da Silva Bortoleti BT, Camargo PG, Gonçalves MD, Tomiotto-Pellissier F, Silva TF, Concato VM, Detoni MB, Bidóia DL, da Silva Lima CH, Rodrigues CR, Bispo MLF, de Macedo FC Jr, Conchon-Costa I, Miranda-Sapla MM, Wowk PF, and Pavanelli WR
- Subjects
- Animals, Mice, Humans, Membrane Potential, Mitochondrial drug effects, Sheep, Antiprotozoal Agents pharmacology, Antiprotozoal Agents chemistry, Erythrocytes drug effects, Erythrocytes parasitology, Erythrocytes metabolism, Cell Line, Leishmania mexicana drug effects, Leishmania mexicana metabolism, THP-1 Cells, Tumor Necrosis Factor-alpha metabolism, Arginine pharmacology, Arginine chemistry, Arginine metabolism, Molecular Docking Simulation, Leishmania drug effects, Reactive Oxygen Species metabolism, Macrophages drug effects, Macrophages metabolism, Macrophages parasitology
- Abstract
Leishmaniasis is a neglected tropical disease caused by parasites of the genus Leishmania and is responsible for more than 1 million new cases and 70,000 deaths annually worldwide. Treatment has high costs, toxicity, complex and long administration time, several adverse effects, and drug-resistant strains, therefore new therapies are urgently needed. Synthetic compounds have been highlighted in the medicinal chemistry field as a strong option for drug development against different diseases. Organic salts (OS) have multiple biological activities, including activity against protozoa such as Leishmania spp. This study aimed to investigate the in vitro leishmanicidal activity and death mechanisms of a thiohydantoin salt derived from l-arginine (ThS) against Leishmania amazonensis. We observed that ThS treatment inhibited promastigote proliferation, increased ROS production, phosphatidylserine exposure and plasma membrane permeabilization, loss of mitochondrial membrane potential, lipid body accumulation, autophagic vacuole formation, cell cycle alteration, and morphological and ultrastructural changes, showing parasites death. Additionally, ThS presents low cytotoxicity in murine macrophages (J774A.1), human monocytes (THP-1), and sheep erythrocytes. ThS in vitro cell treatment reduced the percentage of infected macrophages and the number of amastigotes per macrophage by increasing ROS production and reducing TNF-α levels. These results highlight the potential of ThS among thiohydantoins, mainly related to the arginine portion, as a leishmanicidal drug for future drug strategies for leishmaniasis treatment. Notably, in silico investigation of key targets from L. amazonensis, revealed that a ThS compound from the l-arginine amino acid strongly interacts with arginase (ARG) and TNF-α converting enzyme (TACE), suggesting its potential as a Leishmania inhibitor., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF